Reply from Authors re: Emmanuel S. Antonarakis,Howard I. Scher. Do Patients With AR-V7–Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions. Eur Urol 2017;71:4–6: Unsplicing a Conflict 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Reply from Authors re: Emmanuel S. Antonarakis,Howard I. Scher. Do Patients With AR-V7–Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions. Eur Urol 2017;71:4–6: Unsplicing a Conflict

摘要：
本文献已被 ScienceDirect 等数据库收录！